Interleukin-6 receptor antagonists in critically ill patients with covid-19

The REMAP-CAP Investigators

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Interleukin-6 receptor antagonists in critically ill patients with covid-19'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology